Showing results (171-180 of 361) with videos related to
Sort By:
Pageof 37
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|October 20, 2019
Variation in receipt of therapy and survival with provider volume for medical oncology in non-curative esophago-gastric cancer: a population-based analysisJulie Hallet, Laura E Davis, Alyson L Mahar, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2017
Predictors of and Trends in High-Intensity End-of-Life Care Among Children With Cancer: A Population-Based Study Using Health Services DataAlisha Kassam, Rinku Sutradhar, Kimberley Widger, et al.Palliative Medicine|December 7, 2006
Towards using administrative databases to measure population-based indicators of quality of end-of-life care: testing the methodologyEva Grunfeld, Lynn Lethbridge, Ron Dewar, et al.Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|August 9, 2020
Does the presence of an intact primary increase the risk of nonelective colorectal surgery in patients treated with bevacizumab?N N Baxter, R Sutradhar, F Dossa, et al.BMC Medical Research Methodology|November 24, 2018
Variable participation of knowledge users in cancer health services research: results of a multiple case studyMary Ann O'Brien, Andrea Carson, Lisa Barbera, et al.Journal of General Internal Medicine|March 16, 2007
Lower use of hospice by cancer patients who live in minority versus white areasJennifer S Haas, Craig C Earle, John E Orav, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 8, 2011
Lung cancer treatment costs, including patient responsibility, by disease stage and treatment modality, 1992 to 2003Lauren E Cipriano, Dorothy Romanus, Craig C Earle, et al.Gynecologic Oncology|June 22, 2014
Intraperitoneal chemotherapy among women in the Medicare population with epithelial ovarian cancerKathleen M Fairfield, Kimberly Murray, Jason A LaChance, et al.Cancer|August 25, 2010
How does initial treatment choice affect short-term and long-term costs for clinically localized prostate cancer?Claire F Snyder, Kevin D Frick, Amanda L Blackford, et al.Plos One|October 11, 2017
Cost-effectiveness analysis of treatment with non-curative or palliative intent for hepatocellular carcinoma in the real-world settingHla-Hla Thein, Yao Qiao, Ahmad Zaheen, et al.Pageof 37